Live at SynBioBeta
Each year, SynBioBeta hosts the The Global Synthetic Biology Conference to showcase the latest cutting-edge developments in biology that...
Live at SynBioBeta
Leveraging Synthetic Biology for Resilient Pharma Supply Chains and Accessible Medicines
Advancing the U.S. Bioeconomy and Building Resilient Pharmaceutical Supply Chains
Synthetic Chemistry in Pharma
Antheia Appoints John Nicols to Chair its Board of Directors
In the News: Forbes' Top Ten Women Founders in the Synthetic Biology Industry
Introducing Jesse Ahrendt, Antheia’s SVP of Quality Assurance & Regulatory Affairs
Synthetic Biology vs Synthetic Chemistry: A Primer
Antheia's 2022 in Review: A Year of Value
In the News: Drug Discovery and Development 2023 Predictions
Antheia CEO on How Biomanufacturing can De-Risk Pharmaceutical Production
In the News: Contract Pharma, Leveraging Fermentation to Produce Complex APIs
Antheia CEO Presents at CPHI on Transforming Pharma Supply Chains [Watch]
Demystifying Synthetic Biology Part V: The Product is Key in Downstream Processing
Introducing Guerin Kob, Antheia’s VP of Supply Chain
Demystifying Synthetic Biology IV: Fermentation Bioprocess Development
Antheia Announces New Financing and Plans to Construct Pilot Plant Facility for Biomanufacturing
Demystifying Synthetic Biology III: The 21st Century Technologies Advancing Synthetic Biology
Introducing CPO Heidi Pucel
In the News: Antheia Senior Scientist Involved in Cancer Research Discovery